Find out how CRISPR technology is being applied to advance our understanding of macrophage differentiation and open up new therapeutic avenues in this literature review.

In this article, you will get insights into:

• How a whole-genome CRISPR knockout screening can be used to identify an inhibitor to modulate the pro-inflammatory function of macrophages.
• The methods and experimental design used for the study.
• Approaches adopted to confirm the findings and accelerate translation to the clinic
• The implications of the study for inflammatory disease treatment.

Why drug discovery leaders should read this literature review:

This case study demonstrates how advanced genomic screening can accelerate target identification and validation for complex immunological disorders. The identification of MAP2K3 as a druggable target regulating macrophage differentiation and inflammatory function provided the authors with promising avenues for therapeutic development.

For research use only. Not for use in diagnostic procedures.